1. Home >
  2. Companies >
  3. Public >
  4. Life Science >
  5. United States >
  6. California >
  7. Halozyme >
  8. M&A

Halozyme Mergers & Acquisitions

Halozyme M&A Summary

Halozyme has acquired 2 companies, including 2 in the last 5 years.

Halozyme’s largest acquisition to date was in 2022, when it acquired Antares Pharma for $960M. Halozyme has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 1

Halozyme

Halozyme Therapeutics, Inc.

12390 El Camino Real,
San Diego, California 92130
United States,
(858) 794-8889
www.halozyme.com

All (2) Buy (2) Sell (-)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2025-10-01 Elektrofi · Life Science
Boston, Massachusetts · www.elektrofi.com

Elektrofi is a biopharmaceutical formulation technology company that focuses on monoclonal antibodies, therapeutic proteins, and other large-molecule drugs. Elektrofi is based in Boston, Massachusetts.

Advisors: Centerview Partners , Morgan Lewis 		750 Add-on Acquisition

Halozyme
Advisors: BofA Securities , Weil Gotshal & Manges

-

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal